
Maintaining zzso with zzso agents is hindered by a number of adverse effects including zzso zzso necrosis factor zzso is one of the zzso responsible for the fatigue and zzso associated with zzso We used zzso zzso zzso to maintain zzso of weekly zzso 

Initially, 12 patients with advanced zzso were randomly assigned to either zzso 43 zzso weekly alone zzso zzso or the same zzso dose plus zzso 25 zzso zzso twice weekly zzso zzso zzso higher doses of zzso in combination with zzso were zzso zzso zzso nuclear zzso B zzso zzso and zzso zzso levels were zzso Patients completed weekly questionnaires zzso zzso 

zzso of 36 intended zzso doses during the first cycle were delivered in cohort A, and 35 of 36 doses were delivered in cohort B zzso zzso zzso Three cohort B patients received additional cycles in the absence of disease progression or severe zzso whereas no patients from cohort A received additional zzso zzso to zzso 52 zzso weekly with zzso resulted in zzso not fatigue, as the limiting adverse effect, and the addition of zzso permitted the maintenance of zzso in additional zzso Patients randomly selected to receive zzso zzso less fatigue zzso zzso zzso and zzso zzso show no relevant influence of zzso zzso zzso and increased expression of zzso were associated with increments in zzso zzso zzso activity was noticed exclusively in patients receiving zzso 

The addition of zzso is safe and had no impact on zzso zzso The significant improvement in zzso and the trend toward preservation of zzso suggests further exploration of zzso blockade as an adjunct to cancer zzso 

